[Beta blocker prevention of hemorrhages from esophageal varices in liver cirrhosis].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004932:Esophageal and Gastric Varices / Q000150:complications* / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D010919:Placebos; D011433:Propranolol / Q000627:therapeutic use; D011897:Random Allocation; D012597:Sclerosing Solutions / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D010919:Placebos; D012597:Sclerosing Solutions; D011433:Propranolol
Beta-Blocker-Prophylaxe von Osophagusvarizenblutungen bei Leberzirrhose.